Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 349

1.

Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy.

Nielsen N, Wrist Lam G, Fabrin K, Holt P, Thind PO, Jensen JB.

Scand J Urol. 2019 Jun 7:1-4. doi: 10.1080/21681805.2019.1624608. [Epub ahead of print]

PMID:
31174449
2.

No added value of 18F-sodium fluoride PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer with normal bone scintigraphy.

Zacho H, Jochumsen MR, Langkilde NC, Mortensen JC, Haarmark C, Hendel HW, Jensen JB, Petersen LJ.

J Nucl Med. 2019 May 30. pii: jnumed.119.229062. doi: 10.2967/jnumed.119.229062. [Epub ahead of print]

PMID:
31147402
3.

Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma.

Christensen E, Birkenkamp-Demtröder K, Sethi H, Shchegrova S, Salari R, Nordentoft I, Wu HT, Knudsen M, Lamy P, Lindskrog SV, Taber A, Balcioglu M, Vang S, Assaf Z, Sharma S, Tin AS, Srinivasan R, Hafez D, Reinert T, Navarro S, Olson A, Ram R, Dashner S, Rabinowitz M, Billings P, Sigurjonsson S, Andersen CL, Swenerton R, Aleshin A, Zimmermann B, Agerbæk M, Lin CJ, Jensen JB, Dyrskjøt L.

J Clin Oncol. 2019 May 6:JCO1802052. doi: 10.1200/JCO.18.02052. [Epub ahead of print]

PMID:
31059311
4.

Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover study.

Schmidt S, Christensen MB, Serifovski N, Damm-Frydenberg C, Jensen JB, Fløyel T, Størling J, Ranjan A, Nørgaard K.

Diabetes Obes Metab. 2019 Jul;21(7):1680-1688. doi: 10.1111/dom.13725. Epub 2019 Apr 21.

PMID:
30924570
5.

Early Warning Signs and Rapid Response on the Nursing Floor-Can We Do More?

Sims CCR, Elmer J, Jensen JB.

Int Anesthesiol Clin. 2019 Spring;57(2):61-74. doi: 10.1097/AIA.0000000000000228. No abstract available.

PMID:
30864991
6.

Evaluation of Hospital-Based Hematuria Diagnosis and Subsequent Cancer Risk Among Adults in Denmark.

Nørgaard M, Veres K, Ording AG, Djurhuus JC, Jensen JB, Sørensen HT.

JAMA Netw Open. 2018 Nov 2;1(7):e184909. doi: 10.1001/jamanetworkopen.2018.4909.

7.

Correlation between organ-specific co-morbidities and complications in bladder cancer patients undergoing radical cystectomy.

Elmussareh M, Simonsen PC, Young M, Kingo PS, Jakobsen JK, Jensen JB.

Scand J Urol. 2018 Oct - Dec;52(5-6):395-400. doi: 10.1080/21681805.2018.1531921. Epub 2019 Jan 9.

PMID:
30624138
8.

A validated algorithm to identify recurrence of bladder cancer: a register-based study in Denmark.

Rasmussen LA, Jensen H, Virgilsen LF, Jensen JB, Vedsted P.

Clin Epidemiol. 2018 Nov 26;10:1755-1763. doi: 10.2147/CLEP.S177305. eCollection 2018.

9.

Human papillomavirus and squamous cell carcinoma of the urinary bladder: DaBlaCa-10 study.

Jørgensen KR, Høyer S, Jakobsen JK, Jensen TK, Marcussen N, Wrist Lam G, Hasselager T, Thind PO, Toft BG, Steiniche T, Jensen JB.

Scand J Urol. 2018 Oct - Dec;52(5-6):371-376. doi: 10.1080/21681805.2018.1531920. Epub 2018 Dec 11.

PMID:
30526165
10.

Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes.

Steffensen EH, Cary C, Jensen JB, Larsson H, Weiner M, Nørgaard M.

BMC Cancer. 2018 Oct 24;18(1):1035. doi: 10.1186/s12885-018-4939-8.

11.

Robot-assisted laparoscopic cystectomy with intracorporeal urinary diversion vs. open mini-laparotomy cystectomy: evaluation of surgical inflammatory response and immunosuppressive ability of CO2-pneumoperitoneum in an experimental porcine study.

Kingo PS, Rasmussen TM, Jakobsen LK, Palmfeldt J, Nørregaard R, Borre M, Jensen JB.

Scand J Urol. 2018 Aug;52(4):249-255. doi: 10.1080/21681805.2018.1484508. Epub 2018 Sep 6.

PMID:
30185097
12.

[Diagnostics and treatment of hypophosphatasia].

Hepp N, Frederiksen AL, Khosravi J, Jensen JB.

Ugeskr Laeger. 2018 Aug 27;180(35). pii: V10170736. Danish.

PMID:
30152322
13.

Osteogenesis imperfecta and the teeth, eyes, and ears-a study of non-skeletal phenotypes in adults.

Hald JD, Folkestad L, Swan CZ, Wanscher J, Schmidt M, Gjørup H, Haubek D, Leonhard CH, Larsen DA, Hjortdal JØ, Harsløf T, Duno M, Lund AM, Jensen JB, Brixen K, Langdahl B.

Osteoporos Int. 2018 Dec;29(12):2781-2789. doi: 10.1007/s00198-018-4663-x. Epub 2018 Aug 24.

PMID:
30143849
14.

Unmet informational and supportive care needs of patients with muscle invasive bladder cancer: A systematic review of the evidence.

Paterson C, Jensen BT, Jensen JB, Nabi G.

Eur J Oncol Nurs. 2018 Aug;35:92-101. doi: 10.1016/j.ejon.2018.05.006. Epub 2018 Jun 30. Review.

PMID:
30057091
15.

STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder Cancer.

Lelo A, Prip F, Harris BT, Solomon D, Berry DL, Chaldekas K, Kumar A, Simko J, Jensen JB, Bhattacharyya P, Mannion C, Kim JS, Philips G, Dyrskjøt L, Waldman T.

Clin Cancer Res. 2018 Sep 1;24(17):4145-4153. doi: 10.1158/1078-0432.CCR-17-3244. Epub 2018 Jun 28.

PMID:
29954776
16.

68Ga-PSMA PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: A Prospective, 2-Center Study.

Zacho HD, Nielsen JB, Dettmann K, Haberkorn U, Langkilde NC, Jensen JB, Petersen LJ.

Clin Nucl Med. 2018 Aug;43(8):579-585. doi: 10.1097/RLU.0000000000002169.

PMID:
29916917
17.

Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer.

Zacho HD, Nielsen JB, Afshar-Oromieh A, Haberkorn U, deSouza N, De Paepe K, Dettmann K, Langkilde NC, Haarmark C, Fisker RV, Arp DT, Carl J, Jensen JB, Petersen LJ.

Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1884-1897. doi: 10.1007/s00259-018-4058-4. Epub 2018 Jun 6.

PMID:
29876619
18.

Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro.

Breining P, Jensen JB, Sundelin EI, Gormsen LC, Jakobsen S, Busk M, Rolighed L, Bross P, Fernandez-Guerra P, Markussen LK, Rasmussen NE, Hansen JB, Pedersen SB, Richelsen B, Jessen N.

Diabetes Obes Metab. 2018 Sep;20(9):2264-2273. doi: 10.1111/dom.13362. Epub 2018 Jun 8.

PMID:
29752759
19.

Red patches during bladder cancer surveillance: to biopsy or not to biopsy?

Drejer D, Jensen JB, Bryan RT.

Transl Androl Urol. 2018 Apr;7(2):280-282. doi: 10.21037/tau.2018.03.10. No abstract available.

20.

Prehabilitation for major abdominal urologic oncology surgery.

Jensen BT, Lauridsen SV, Jensen JB.

Curr Opin Urol. 2018 May;28(3):243-250. doi: 10.1097/MOU.0000000000000487.

PMID:
29538165
21.

Persistent organic pollutants and penile bone mineral density in East Greenland and Canadian polar bears (Ursus maritimus) during 1996-2015.

Daugaard-Petersen T, Langebæk R, Rigét FF, Dyck M, Letcher RJ, Hyldstrup L, Jensen JB, Dietz R, Sonne C.

Environ Int. 2018 May;114:212-218. doi: 10.1016/j.envint.2018.02.022. Epub 2018 Mar 6.

PMID:
29522985
22.

Fracture risk in women with type II diabetes. Results from a historical cohort with fracture follow-up.

Holm JP, Jensen T, Hyldstrup L, Jensen JB.

Endocrine. 2018 Apr;60(1):151-158. doi: 10.1007/s12020-018-1564-x. Epub 2018 Feb 16.

PMID:
29453659
23.

Optimized targeted sequencing of cell-free plasma DNA from bladder cancer patients.

Christensen E, Nordentoft I, Vang S, Birkenkamp-Demtröder K, Jensen JB, Agerbæk M, Pedersen JS, Dyrskjøt L.

Sci Rep. 2018 Jan 30;8(1):1917. doi: 10.1038/s41598-018-20282-8.

24.

Molecular Markers Increase Precision of the European Association of Urology Non-Muscle-Invasive Bladder Cancer Progression Risk Groups.

van Kessel KEM, van der Keur KA, Dyrskjøt L, Algaba F, Welvaart NYC, Beukers W, Segersten U, Keck B, Maurer T, Simic T, Horstmann M, Grimm MO, Hermann GG, Mogensen K, Hartmann A, Harving N, Petersen AC, Jensen JB, Junker K, Boormans JL, Real FX, Malats N, Malmström PU, Ørntoft TF, Zwarthoff EC.

Clin Cancer Res. 2018 Apr 1;24(7):1586-1593. doi: 10.1158/1078-0432.CCR-17-2719. Epub 2018 Jan 24.

25.

Persistent organic pollutants, skull size and bone density of polar bears (Ursus maritimus) from East Greenland 1892-2015 and Svalbard 1964-2004.

Daugaard-Petersen T, Langebæk R, Rigét FF, Letcher RJ, Hyldstrup L, Jensen JB, Bechshoft T, Wiig Ø, Jenssen BM, Pertoldi C, Lorenzen ED, Dietz R, Sonne C.

Environ Res. 2018 Apr;162:74-80. doi: 10.1016/j.envres.2017.12.009. Epub 2017 Dec 26.

PMID:
29287182
26.

Expanding the Presence of Primary Services at Rapid Response Team Activations: A Quality Improvement Project.

Gallo de Moraes A, OʼHoro JC, Sevilla-Berrios RA, Iacovella G, Lenhertz A, Schmidt J, Elmer J, Oeckler R, Caples S, Jensen JB.

Qual Manag Health Care. 2018 Jan/Mar;27(1):50-55. doi: 10.1097/QMH.0000000000000159.

PMID:
29280908
27.

Reliability and Validity of the Checklist for Early Recognition and Treatment of Acute Illness and Injury as a Charting Tool in the Medical Intensive Care Unit.

Kogan A, Pennington KM, Vallabhajosyula S, Dziadzko M, Bennett CE, Jensen JB, Gajic O, O'Horo JC.

Indian J Crit Care Med. 2017 Nov;21(11):746-750. doi: 10.4103/ijccm.IJCCM_209_17.

28.

Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients.

Chan OTM, Furuya H, Pagano I, Shimizu Y, Hokutan K, Dyrskjøt L, Jensen JB, Malmstrom PU, Segersten U, Janku F, Rosser CJ.

Oncotarget. 2017 Sep 6;8(59):99707-99721. doi: 10.18632/oncotarget.20686. eCollection 2017 Nov 21.

29.

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension.

Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M, Roux C, Törring O, Valter I, Wang AT, Brown JP.

J Bone Miner Res. 2018 Feb;33(2):190-198. doi: 10.1002/jbmr.3337. Epub 2017 Nov 22.

30.

Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis.

Birkenkamp-Demtröder K, Christensen E, Nordentoft I, Knudsen M, Taber A, Høyer S, Lamy P, Agerbæk M, Jensen JB, Dyrskjøt L.

Eur Urol. 2018 Apr;73(4):535-540. doi: 10.1016/j.eururo.2017.09.011. Epub 2017 Sep 27.

PMID:
28958829
31.

Comprehensive multiregional analysis of molecular heterogeneity in bladder cancer.

Thomsen MBH, Nordentoft I, Lamy P, Vang S, Reinert L, Mapendano CK, Høyer S, Ørntoft TF, Jensen JB, Dyrskjøt L.

Sci Rep. 2017 Sep 15;7(1):11702. doi: 10.1038/s41598-017-11291-0.

32.

[The significance of HIV to bone mineral density].

Wessman M, Weis N, Katzenstein TL, Lebech AM, Thorsteinsson K, Hansen AE, Jensen JB.

Ugeskr Laeger. 2017 Sep 4;179(36). pii: V05170420. Review. Danish.

PMID:
28874254
33.

Results from 11C-metformin-PET scans, tissue analysis and cellular drug-sensitivity assays questions the view that biguanides affects tumor respiration directly.

Iversen AB, Horsman MR, Jakobsen S, Jensen JB, Garm C, Jessen N, Breining P, Frøkiær J, Busk M.

Sci Rep. 2017 Aug 25;7(1):9436. doi: 10.1038/s41598-017-10010-z.

34.

Bone turnover is altered in transgenic rats overexpressing the P2Y2 purinergic receptor.

Ellegaard M, Agca C, Petersen S, Agrawal A, Kruse LS, Wang N, Gartland A, Jensen JB, Jørgensen NR, Agca Y.

Purinergic Signal. 2017 Dec;13(4):545-557. doi: 10.1007/s11302-017-9582-3. Epub 2017 Aug 21.

35.

Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?

Azawi NH, Berg KD, Thamsborg AKM, Dahl C, Jepsen JV, Kroman-Andersen B, Poulsen J, Petersen HH, Henning Olsen L, Jensen JB.

Int Urol Nephrol. 2017 Oct;49(10):1785-1792. doi: 10.1007/s11255-017-1672-1. Epub 2017 Jul 31.

PMID:
28762118
36.

Efficacy of commercialised extracorporeal shock wave lithotripsy service: a review of 589 renal stones.

Nielsen TK, Jensen JB.

BMC Urol. 2017 Jul 27;17(1):59. doi: 10.1186/s12894-017-0249-8.

37.
38.

Perioperative Systemic Inflammatory Response following Robot-Assisted Laparoscopic Cystectomy vs. Open Mini-Laparotomy Cystectomy: A Prospective Study.

Skjold Kingo P, Palmfeldt J, Nørregaard R, Borre M, Jensen JB.

Urol Int. 2017;99(4):436-445. doi: 10.1159/000478274. Epub 2017 Jul 1.

PMID:
28668947
39.

Asymptomatic microscopic hematuria as a predictor of neoplasia in the urinary tract.

Ordell Sundelin M, Jensen JB.

Scand J Urol. 2017 Oct;51(5):373-375. doi: 10.1080/21681805.2017.1334699. Epub 2017 Jun 23.

PMID:
28644736
40.

Vitamin D insufficiency, preterm delivery and preeclampsia in women with type 1 diabetes - an observational study.

Vestgaard M, Secher AL, Ringholm L, Jensen JB, Damm P, Mathiesen ER.

Acta Obstet Gynecol Scand. 2017 Oct;96(10):1197-1204. doi: 10.1111/aogs.13180. Epub 2017 Jul 7.

PMID:
28590567
41.

Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study.

Dyrskjøt L, Reinert T, Algaba F, Christensen E, Nieboer D, Hermann GG, Mogensen K, Beukers W, Marquez M, Segersten U, Høyer S, Ulhøi BP, Hartmann A, Stöhr R, Wach S, Nawroth R, Schwamborn K, Tulic C, Simic T, Junker K, Harving N, Petersen AC, Jensen JB, Keck B, Grimm MO, Horstmann M, Maurer T, Steyerberg EW, Zwarthoff EC, Real FX, Malats N, Malmström PU, Ørntoft TF.

Eur Urol. 2017 Sep;72(3):461-469. doi: 10.1016/j.eururo.2017.05.040. Epub 2017 Jun 2.

PMID:
28583312
42.

Efficacy of preoperative uro-stoma education on self-efficacy after Radical Cystectomy; secondary outcome of a prospective randomized controlled trial.

Jensen BT, Kiesbye B, Soendergaard I, Jensen JB, Kristensen SA.

Eur J Oncol Nurs. 2017 Jun;28:41-46. doi: 10.1016/j.ejon.2017.03.001. Epub 2017 Mar 18.

PMID:
28478854
43.

A high-protein diet during hospitalization is associated with an accelerated decrease in soluble urokinase plasminogen activator receptor levels in acutely ill elderly medical patients with SIRS.

Tavenier J, Haupt TH, Andersen AL, Buhl SF, Langkilde A, Andersen JR, Jensen JB, Pedersen MM, Petersen J, Andersen O.

Nutr Res. 2017 May;41:56-64. doi: 10.1016/j.nutres.2017.04.006. Epub 2017 Apr 20.

PMID:
28477944
44.

Outcomes of haematuria referrals: two-year data from a single large university hospital in Denmark.

Elmussareh M, Young M, Ordell Sundelin M, Bak-Ipsen CB, Graumann O, Jensen JB.

Scand J Urol. 2017 Aug;51(4):282-289. doi: 10.1080/21681805.2017.1310759. Epub 2017 Apr 13.

PMID:
28406341
45.

Voided urine versus bladder washing cytology for detection of urothelial carcinoma: which is better?

Keller AK, Jensen JB.

Scand J Urol. 2017 Aug;51(4):290-292. doi: 10.1080/21681805.2017.1310130. Epub 2017 Apr 11.

PMID:
28398114
46.

Genetic Polymorphisms in Organic Cation Transporter 1 Attenuates Hepatic Metformin Exposure in Humans.

Sundelin E, Gormsen LC, Jensen JB, Vendelbo MH, Jakobsen S, Munk OL, Christensen M, Brøsen K, Frøkiaer J, Jessen N.

Clin Pharmacol Ther. 2017 Nov;102(5):841-848. doi: 10.1002/cpt.701. Epub 2017 Jun 1.

PMID:
28380657
47.

Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.

Seitz AK, Christensen LL, Christensen E, Faarkrog K, Ostenfeld MS, Hedegaard J, Nordentoft I, Nielsen MM, Palmfeldt J, Thomson M, Jensen MT, Nawroth R, Maurer T, Ørntoft TF, Jensen JB, Damgaard CK, Dyrskjøt L.

Sci Rep. 2017 Mar 24;7(1):395. doi: 10.1038/s41598-017-00327-0.

48.

Clinical relevance of narrow-band imaging in flexible cystoscopy: the DaBlaCa-7 study.

Drejer D, Béji S, Munk Nielsen A, Høyer S, Wrist Lam G, Jensen JB.

Scand J Urol. 2017 Apr;51(2):120-123. doi: 10.1080/21681805.2017.1295101. Epub 2017 Mar 7.

PMID:
28266904
49.

Human papillomavirus types 44, 52, 66 and 67 detected in a woman with squamous cell carcinoma of the urinary bladder.

Jørgensen KR, Høyer S, Sørensen MM, Jensen JB.

Scand J Urol. 2017 Feb;51(1):85-86. doi: 10.1080/21681805.2016.1271826. Epub 2017 Jan 13.

PMID:
28084874
50.

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.

Christensen E, Birkenkamp-Demtröder K, Nordentoft I, Høyer S, van der Keur K, van Kessel K, Zwarthoff E, Agerbæk M, Ørntoft TF, Jensen JB, Dyrskjøt L.

Eur Urol. 2017 Jun;71(6):961-969. doi: 10.1016/j.eururo.2016.12.016. Epub 2017 Jan 6.

PMID:
28069289

Supplemental Content

Loading ...
Support Center